duloxetine hydrochloride has been researched along with reserpine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Fan, DS; Guo, L; Ji, CX; Li, W; Liang, ZL; Xu, RM; Zhang, JJ | 1 |
| Aoki, T; Fushiki, H; Honda, S; Irie, M; Iwashita, A; Murai, N; Murakami, Y; Nagakura, Y; Tamura, S | 1 |
| Asaki, T; Hasegawa, M; Ishida, M; Shinohara, S; Tamano, R | 1 |
| Abd El Fattah, MA; Kenawy, SA; Radwan, RR; Shabaan, EA; Shibrya, EE | 1 |
| Blasco-Serra, A; Cervera-Ferri, A; González-Soler, EM; Teruel-MartĂ, V; Valverde-Navarro, AA | 1 |
6 other study(ies) available for duloxetine hydrochloride and reserpine
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Evaluation of the anti-ulcerogenic activity of the antidepressants duloxetine, amitriptyline, fluoxetine and mirtazapine in different models of experimental gastric ulcer in rats.
Topics: Amitriptyline; Animals; Anti-Ulcer Agents; Antidepressive Agents; Disease Models, Animal; Duloxetine Hydrochloride; Fluoxetine; Immersion; Indomethacin; Male; Mianserin; Mirtazapine; Rats; Rats, Sprague-Dawley; Reserpine; Restraint, Physical; Stomach Ulcer; Stress, Psychological; Thiophenes; Water | 2012 |
Relationship between serotonin transporter occupancies and analgesic effects of AS1069562, the (+)-isomer of indeloxazine, and duloxetine in reserpine-induced myalgia rats.
Topics: Analgesics; Animals; Brain; Chronic Pain; Disease Models, Animal; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Hyperalgesia; Male; Morpholines; Myalgia; Pain Threshold; Pressure; Rats, Sprague-Dawley; Reserpine; Serotonin Plasma Membrane Transport Proteins; Treatment Outcome | 2015 |
Effect of spinal monoaminergic neuronal system dysfunction on pain threshold in rats, and the analgesic effect of serotonin and norepinephrine reuptake inhibitors.
Topics: Administration, Cutaneous; Analgesics; Animals; Biogenic Monoamines; Brain; Chronic Pain; Cyclopropanes; Duloxetine Hydrochloride; Injections, Spinal; Milnacipran; Neurons; Norepinephrine; Pain Threshold; Rats, Sprague-Dawley; Reserpine; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors; Spinal Cord; Vesicular Monoamine Transport Proteins | 2016 |
Evidences for amelioration of reserpine-induced fibromyalgia in rat by low dose of gamma irradiation and duloxetine.
Topics: Analgesics; Animals; Chemoradiotherapy; Duloxetine Hydrochloride; Fibromyalgia; Gamma Rays; Male; Radiotherapy Dosage; Rats; Rats, Wistar; Reserpine; Treatment Outcome | 2017 |
A standardization of the Novelty-Suppressed Feeding Test protocol in rats.
Topics: Animals; Antidepressive Agents; Depression; Depressive Disorder; Disease Models, Animal; Duloxetine Hydrochloride; Exploratory Behavior; Male; Rats, Sprague-Dawley; Reproducibility of Results; Reserpine | 2017 |